Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Neurological and cognitive problems news

Show

From To
Traditional risk factors predict neurocognitive impairment in people with HIV

Neurocognitive impairment in people with HIV – loss of memory, poor concentration and declining mental ability – is most likely to be happening for the

Published
31 October 2012
By
Michael Carter
Efavirenz and the brain: are we nearer to solving a mysterious side-effect?

One of the most potent HIV drugs, efavirenz, unfortunately also causes mysterious and sometimes chronic disruptions of mood, thought and sleep. Researchers may have found the key to

Published
22 October 2012
From
HIV treatment update
Cognitive training helps adults with HIV

Cognitive training exercises can help improve mental processing speed and ability to complete daily tasks in middle-age and older adults with HIV, a population that is experiencing cognitive impairments at a higher rate than those without the disease.

Published
17 October 2012
From
Science Daily
European guidelines on management of mental health for people with hepatitis C published

European investigators have developed a consensus statement on hepatitis C and mental health. Published in the online edition of the Journal of Hepatology, the wide-ranging document assesses evidence

Published
16 October 2012
By
Michael Carter
Starting HIV treatment reduces the risk of serious non-AIDS-related diseases

Serious non-AIDS-defining illnesses are common in people recently diagnosed with HIV, Spanish investigators report in the online edition of AIDS. “Clinicians should be aware that during the initial

Published
09 October 2012
By
Michael Carter
Popular HIV drug may cause memory declines

The way the body metabolizes a commonly prescribed anti-retroviral drug that is used long term by patients infected with HIV may contribute to cognitive impairment by damaging nerve cells, a new Johns Hopkins research suggests.

Published
28 September 2012
From
Eurekalert Medicine & Health
Watch for cryptococcal disease in children with HIV, South African doctors warn

Clinicians in low- and middle-income countries should give greater consideration to the possibility that infants and children with HIV are presenting with symptoms of cryptococcal disease, according to

Published
17 September 2012
By
Carole Leach-Lemens
Double trouble: daily function and the impact of old age and HIV

Older age exacerbates the deleterious effect of HIV on daily functioning, investigators from the US report in the online edition of the Journal of Acquired Immune Deficiency Syndromes.

Published
11 September 2012
By
Michael Carter
Detectable viral load and low CD4 cell count are risk factors for shingles in HIV-positive people

A CD4 cell count below 500 cells/mm3 and a detectable viral load are risk factors for herpes zoster (shingles) in HIV-positive people, US investigators report in the

Published
21 August 2012
By
Michael Carter
Hope for patients with HIV-associated cognitive impairment

New research has discovered that a group of plant polyphenols known as catechins, which naturally occur in green tea and the seed of the cacao tree, may help in the prevention of HIV-related neurological complications. The compounds epicatechin epigallocatechin gallate (EGCG), already known for their anti-oxidant properties, were found to induce a protein called brain-derived neurotrophic factor (BDNF), which supports the survival and growth of neurons in the brain. This protein is active in areas of the brain vital to learning, memory and higher thinking.

Published
15 August 2012
From
EurekAlert

Filter by country